Novo Holdings A/S bought MPLT
October 28, 2025 · Form 4 insider transaction
Novo Holdings A/S bought 2,733,681 shares of MapLight Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,733,681
Price
N/A
Total value
N/A
InsiderNovo Holdings A/S
Role10% owner
SecurityVoting Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after2,733,681
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.